Article Text

GW24-e2232 Principal role of heparanase in angiogenesis of hypoxia preconditioned mesenchymal stem cells
  1. Xinyang Hu,
  2. Jian-An Wang
  1. Department of Cardiology, Key Lab of Cardiovascular Disease, Second Affiliated Hospital of Zhejiang University School of Medicine


Objectives Heparanase is an endoglycosidase involved in the cleavage of the heparin sulfate and plays important roles in tumour metastasis and angiogenesis. The purpose of the present study was to investigate the important role of heparanase in hypoxia-preconditioned bone marrow-derived mesenchymal stem cells (MSCs) induced angiogenesis.

Methods Heparanase gene knock-down and overexpression were used to detect the MSCs angiogenesis with or without hypoxia preconditioning. Moreover, in vivo experiments on rats with ligation of left anterior descending artery were performed to study the angiogenesis of heparanase-overexpressing MSCs.

Results Here we showed hypoxia-preconditioning markedly induced heparanase expression and reduced heparanase precursor expression in rat MSCs. Suramin, a heparanse inhibitor, decreased heparanase in MSCs and blocked hypoxia preconditioning-induced MSCs angiogenesis. Furthermore, heparanase knock-down impaired hypoxia preconditioning-induced MSCs angiogenesis by down-regulation of p38 phosphorylation, VEGF and flk-1 expression. While stable overexpression of heparanase activated this process in vitro and in vivo.

Conclusions In conclusion, our studies suggest that heparanse may regulate hypoxia preconditioning-induced MSCs angiogenesis through MAPK-p38 pathway.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.